Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/EBIT(x) 26.9127.3647.7027.698.47

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 26.91 based on Mar2026 Consolidated results.
Year EV/EBIT
Mar202626.91
Mar202527.36
Mar202447.70
Mar202327.69
Mar20228.47

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2026 26.91
-1.64
Mar2025 27.36
-42.64
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹65,930.4 Cr -2% -5.2% 13.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2%

-5.2%

13.7%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses